- Application under evaluation
- CVMP opinion
- European Commission decision
Overview
The marketing authorisation for this product has been withdrawn at the request of the marketing authorisation holder.
Activyl Tick Plus : EPAR - Medicine overview
English (EN) (638.56 KB - PDF)
български (BG) (833.05 KB - PDF)
español (ES) (637.97 KB - PDF)
čeština (CS) (707.44 KB - PDF)
dansk (DA) (636.99 KB - PDF)
Deutsch (DE) (638.67 KB - PDF)
eesti keel (ET) (636.23 KB - PDF)
ελληνικά (EL) (842.43 KB - PDF)
français (FR) (638.87 KB - PDF)
hrvatski (HR) (657.6 KB - PDF)
italiano (IT) (637.31 KB - PDF)
latviešu valoda (LV) (717.67 KB - PDF)
lietuvių kalba (LT) (659.32 KB - PDF)
magyar (HU) (781.33 KB - PDF)
Malti (MT) (710.54 KB - PDF)
Nederlands (NL) (637.34 KB - PDF)
polski (PL) (786.25 KB - PDF)
português (PT) (637.89 KB - PDF)
română (RO) (667.24 KB - PDF)
slovenčina (SK) (708.71 KB - PDF)
slovenščina (SL) (699.93 KB - PDF)
Suomi (FI) (637.11 KB - PDF)
svenska (SV) (637.61 KB - PDF)
Product information
Activyl Tick Plus : EPAR - Product Information
English (EN) (1.08 MB - PDF)
български (BG) (2.52 MB - PDF)
español (ES) (1.03 MB - PDF)
čeština (CS) (1.53 MB - PDF)
dansk (DA) (1.07 MB - PDF)
Deutsch (DE) (1.04 MB - PDF)
eesti keel (ET) (1.02 MB - PDF)
ελληνικά (EL) (2.58 MB - PDF)
français (FR) (1.03 MB - PDF)
hrvatski (HR) (1.13 MB - PDF)
íslenska (IS) (1.19 MB - PDF)
italiano (IT) (1.04 MB - PDF)
latviešu valoda (LV) (1.51 MB - PDF)
lietuvių kalba (LT) (1.15 MB - PDF)
magyar (HU) (2.01 MB - PDF)
Malti (MT) (1.56 MB - PDF)
Nederlands (NL) (989.45 KB - PDF)
norsk (NO) (1.15 MB - PDF)
polski (PL) (2 MB - PDF)
português (PT) (1.02 MB - PDF)
română (RO) (1.17 MB - PDF)
slovenčina (SK) (1.5 MB - PDF)
slovenščina (SL) (1.43 MB - PDF)
Suomi (FI) (1.07 MB - PDF)
svenska (SV) (1.03 MB - PDF)
Activyl Tick Plus : EPAR - All Authorised presentations
English (EN) (603.35 KB - PDF)
български (BG) (702.52 KB - PDF)
español (ES) (627.24 KB - PDF)
čeština (CS) (635.54 KB - PDF)
dansk (DA) (603.91 KB - PDF)
Deutsch (DE) (607.63 KB - PDF)
eesti keel (ET) (601.07 KB - PDF)
ελληνικά (EL) (1.3 MB - PDF)
français (FR) (615.71 KB - PDF)
italiano (IT) (601.55 KB - PDF)
latviešu valoda (LV) (676.21 KB - PDF)
lietuvių kalba (LT) (606.83 KB - PDF)
magyar (HU) (636.93 KB - PDF)
Malti (MT) (640.99 KB - PDF)
Nederlands (NL) (602.69 KB - PDF)
polski (PL) (666.18 KB - PDF)
português (PT) (608.07 KB - PDF)
română (RO) (603.15 KB - PDF)
slovenčina (SK) (636.61 KB - PDF)
slovenščina (SL) (634.11 KB - PDF)
Suomi (FI) (600.94 KB - PDF)
svenska (SV) (603.5 KB - PDF)
Product details
- Name of medicine
- Activyl Tick Plus
- Active substance
- indoxacarb
- permethrin
- International non-proprietary name (INN) or common name
- indoxacarb
- permethrin
- Species
- Dogs
- Anatomical therapeutic chemical veterinary (ATCvet) code
- QP53AC54
Pharmacotherapeutic group
- permethrin, combinations
- Ectoparasiticides for topical use, incl. insecticides
Therapeutic indication
Treatment of flea infestations (Ctenocephalides felis); the product has persistent insecticidal efficacy for up to 4 weeks against Ctenocephalides felis. The product has persistent acaricidal efficacy for up to 5 weeks against Ixodes ricinus and up to 3 weeks against Rhipicephalus sanguineus. One treatment provides repellent (anti-feeding) activity against sand flies (Phlebotomus perniciosus) for up to 3 weeks.
Authorisation details
- EMA product number
- EMEA/V/C/002234
- Marketing authorisation holder
- Intervet International BV
Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands - Opinion adopted
- 10/11/2011
- Marketing authorisation issued
- 09/01/2012
- Revision
- 9
Assessment history
Activyl Tick Plus : EPAR - Procedural steps taken and scientific information after authorisation
English (EN) (744.74 KB - PDF)
CVMP post-authorisation summary of positive opinion for Activyl Tick Plus
English (EN) (623.5 KB - PDF)
Activyl Tick Plus-V-C-2234-II-0008 : EPAR - Assessment Report - Variation
English (EN) (730.05 KB - PDF)
CVMP post-authorisation summary of positive opinion for Activyl Tick Plus
English (EN) (622.43 KB - PDF)
Activyl Tick Plus : EPAR - Public assessment report
English (EN) (778.11 KB - PDF)
CVMP summary of positive opinion for Activyl Tick Plus
English (EN) (609.79 KB - PDF)